The Impact of Flexible-Pricing and Cost-Sharing Schemes on the Commercialization of New Medical Therapies

Funded Research Proposal

The clinical-trial data used to make approval decisions for medical therapies are collected from a relatively small patient sub-populations. Given small sample sizes, trial data may suggest that treatments are medically or economically nonviable, even though they ultimately may be, or vice versa. Read More